Correlation Between Genelux Common and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Genelux Common and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genelux Common and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genelux Common and Monopar Therapeutics, you can compare the effects of market volatilities on Genelux Common and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genelux Common with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genelux Common and Monopar Therapeutics.
Diversification Opportunities for Genelux Common and Monopar Therapeutics
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Genelux and Monopar is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Genelux Common and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Genelux Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genelux Common are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Genelux Common i.e., Genelux Common and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Genelux Common and Monopar Therapeutics
Given the investment horizon of 90 days Genelux Common is expected to under-perform the Monopar Therapeutics. In addition to that, Genelux Common is 1.0 times more volatile than Monopar Therapeutics. It trades about -0.08 of its total potential returns per unit of risk. Monopar Therapeutics is currently generating about 0.09 per unit of volatility. If you would invest 1,783 in Monopar Therapeutics on August 28, 2024 and sell it today you would earn a total of 157.00 from holding Monopar Therapeutics or generate 8.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Genelux Common vs. Monopar Therapeutics
Performance |
| Timeline |
| Genelux Common |
| Monopar Therapeutics |
Genelux Common and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genelux Common and Monopar Therapeutics
The main advantage of trading using opposite Genelux Common and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genelux Common position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Genelux Common vs. Dyadic International | Genelux Common vs. Cingulate | Genelux Common vs. Monopar Therapeutics | Genelux Common vs. Terns Pharmaceuticals |
| Monopar Therapeutics vs. Eliem Therapeutics | Monopar Therapeutics vs. HCW Biologics | Monopar Therapeutics vs. Scpharmaceuticals | Monopar Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |